Decheng Capital China Life Sciences USD Fund III L.P. 13D and 13G filings for Alpine Immune Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-21 4:49 pm Sale |
2024-05-18 | 13D | Alpine Immune Sciences, Inc. ALPN |
Decheng Capital China Life Sciences USD Fund III L.P. | 0 0.000% |
-8,368,166 (Position Closed) |
Filing |
| 2024-04-30 4:20 pm Purchase |
2024-04-10 | 13D | Alpine Immune Sciences, Inc. ALPN |
Decheng Capital China Life Sciences USD Fund III L.P. | 8,368,166 12.800% |
7,292 (+0.09%) |
Filing |
| 2023-11-14 4:16 pm Purchase |
2023-11-09 | 13D | Alpine Immune Sciences, Inc. ALPN |
Decheng Capital China Life Sciences USD Fund III L.P. | 8,360,874 14.100% |
386,667 (+4.85%) |
Filing |
| 2022-09-27 4:00 pm Purchase |
2022-09-23 | 13D | Alpine Immune Sciences, Inc. ALPN |
Decheng Capital China Life Sciences USD Fund III L.P. | 7,974,207 17.600% |
2,010,246 (+33.71%) |
Filing |
| 2021-09-21 5:04 pm Purchase |
2021-09-17 | 13D | Alpine Immune Sciences, Inc. ALPN |
Decheng Capital China Life Sciences USD Fund III L.P. | 5,963,961 19.600% |
1,554,240 (+35.25%) |
Filing |
| 2020-07-31 7:49 pm Purchase |
2020-07-28 | 13D | Alpine Immune Sciences, Inc. ALPN |
Decheng Capital China Life Sciences USD Fund III L.P. | 4,409,721 17.700% |
563,132 (+14.64%) |
Filing |